Drug intelligence / Profile preview

2'-deoxy-thymidine-beta-L-rhamnose

Development stage
Unknown
Modality
Small Molecules
01

Overview

2'-Deoxy-thymidine-beta-L-rhamnose is a pyrimidine nucleotide sugar, specifically a glycosylated derivative of thymidine that incorporates the sugar rhamnose. It is primarily known as a key intermediate in the biosynthesis of dTDP-L-rhamnose, which is an essential precursor for the formation of bacterial cell wall polysaccharides and lipopolysaccharides[1][3][4]. The compound participates in enzymatic reactions catalyzed by glycosyltransferases and reductases such as RmlC and WsaF, which are involved in rhamnan chain assembly[5][8]. Biologically, it has been studied for its potential antiviral activity—by inhibiting viral glycoprotein synthesis—and anticancer properties through disruption of bacterial cell wall biosynthesis and immune modulation[4]. Its mechanism involves incorporation into polysaccharides/glycoproteins, leading to interference with cell wall synthesis or viral replication. It is considered experimental with no approved clinical indications.

Other names
Thymidine diphosphate-L-rhamnosedTDP-6-deoxy-L-mannosedTDP6-deoxy-L-mannosedTDP 6-deoxy-L-mannosedTDP-6-deoxy-beta-L-mannosedTDP6-deoxy-beta-L-mannosedTDP 6-deoxy-beta-L-mannose
02

Targets

Bacterial rhamnosyltransferase

Beyond the preview

Go deeper on 2'-deoxy-thymidine-beta-L-rhamnose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2'-deoxy-thymidine-beta-L-rhamnose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call